In this study, we performed an extensive assessment of the relationships between serum levels of NFL, the main neurochemical biomarker of axonal degeneration, and demographic, clinical motor, neurophysiological, neuropsychological, respiratory, and laboratory features of a large single-center cohort of deeply phenotyped patients with ALS. Here, NEFL is linked to amyotrophic lateral sclerosis.